Debate rages over China’s Covid-19 vaccines

China begins era of strict supervision of financial holding companies In March, about 180 immunologists and epidemiologists with China National Pharmaceutical Industry Corp (SinoPharm), together with their families, signed up to be the first volunteers to receive jabs as the state-owned drugmaker scrambled to develop a Covid-19 vaccine but needed to ascertain its safety and efficacy. Half a year later, as Beijing commits to donating vaccines and sharing formulas and ingredients as “global public goods” with the developing world, those volunteers are reportedly maintaining “significantly high levels” of antibodies against Covid-19. These developments are encouraging according to Dr. Zhang...